Related references
Note: Only part of the references are listed.Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL
Paul J. W. H. Kappelle et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Lower Serum Paraoxonase-1 Activity Is Related to Higher Serum Amyloid A Levels in Metabolic Syndrome
Paul Jan Willem Herman Kappelle et al.
ARCHIVES OF MEDICAL RESEARCH (2011)
Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus
Douwe J. Mulder et al.
ATHEROSCLEROSIS (2011)
Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice
Niels Nijstad et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2011)
Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes
Alexander Constantinides et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Plasma Cholesteryl Ester Transfer, But Not Cholesterol Esterification, Is Related to Lipoprotein-Associated Phospholipase A2: Possible Contribution to an Atherogenic Lipoprotein Profile
Robin P. F. Dullaart et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein
P. J. W. H. Kappelle et al.
JOURNAL OF INTERNAL MEDICINE (2011)
C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians
Elizabeth B. Windgassen et al.
POSTGRADUATE MEDICINE (2011)
Increased Coronary Heart Disease Risk Determined by High High-Density Lipoprotein Cholesterol and C-Reactive Protein: Modulation by Variation in the CETP Gene
Robin P. F. Dullaart
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I
Estelle Nobecourt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins
Pia Davidsson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Inflammation reduces HDL protection against primary cardiac risk
James P. Corsetti et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2
Wijtske Annema et al.
JOURNAL OF LIPID RESEARCH (2010)
A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome
Kazuhiko Kotani et al.
ATHEROSCLEROSIS (2009)
The role of lipoprotein-associated phospholipase A(2) in atherosclerosis may depend on its lipoprotein carrier in plasma
Constantinos C. Tellis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
HDL as a Biomarker, Potential Therapeutic Target, and Therapy
Mohamad Navab et al.
DIABETES (2009)
Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study
M. Jacobs et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study
J. Jylhava et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Helical structure and stability in human apolipoprotein A-I by hydrogen exchange and mass spectrometry
Palaniappan Sevugan Chetty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
Robin P. F. Dullaart et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity
A Kontush et al.
ATHEROSCLEROSIS (2005)
Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress
UJF Tietge et al.
JOURNAL OF LIPID RESEARCH (2005)
Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
A Chait et al.
JOURNAL OF LIPID RESEARCH (2005)
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women - The National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)
BD Johnson et al.
CIRCULATION (2004)
Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity
B Hansel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity
RW James et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus:: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
SE Borggreve et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus
T Kujiraoka et al.
JOURNAL OF LIPID RESEARCH (2003)
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
J Danesh et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Glycation impairs high-density lipoprotein function
CC Hedrick et al.
DIABETOLOGIA (2000)
Share Paper
